
    
      This is an interventional study comparing gold standard anamnesis, thoracic CT and PCR versus
      SARS-Cov-2 antigen, anamnesis and thoracic CT for the diagnosis of COVID-19 infection.

      Patients will be sampled for the tests at Day 1 and then monitored for symptoms and clinical
      data and additional test at Day 21.
    
  